Boston Scientific PE ratio BSX

Share price divided by earnings per share over the last twelve months, since 2011.

Today, Oct 23, 2026: 18.5×
10-year median: 67.0×
Against its 10-year history: 11th; percentile: 0 is its lowest day, 100 its highest
10-year range: 10.8× to 482×
Peer median: 30.9×

Boston Scientific's PE ratio is 18.5× as of Oct 23, 2026: a share price of $45.69 against $2.47 of earnings per share over the last twelve months.

That is below its ten-year median of 67.0×, lower than on 89% of days in the last ten years.

Over that time it ranged from 10.8× in May 2020 to 482× in Jul 2018.

The median for 7 medical device stocks of a similar size is 30.9×.

PE ratio over time

median 67×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	18.5×	17.2×	52.2×
2025	51.4×	49.5×	87.7×
2024	74.9×	60.6×	80.3×
2023	70.5×	62.9×	116×
2022	110×	54.7×	111×
2021	55.2×	13.6×	326×
2020	13.8×	10.8×	59.3×
2019	58.7×	28.6×	85.1×
2018	73.8×	42.5×	482×
2017	40.6×	40.6×	423×
2016	361×	339×	364×
2015	78.4×	63.0×	78.4×
2014	62.7×	45.0×	73.8×
2013	n/m a value too high to mean anything
2012	15.6×	14.3×	21.6×
2011	14.4×	13.5×	21.4×

Against its peers

Companies in Medical - Devices nearest Boston Scientific's size, closest first, today.

Company	PE ratio
BSXBoston Scientific	18.5×
EWEdwards Lifesciences	51.2×
SYKStryker	31.8×
MDTMedtronic	23.4×
GEHCGE HealthCare Technologies	16.4×
DXCMDexCom	30.9×
ABTAbbott Laboratories	38.7×
ZBHZimmer Biomet	24.0×
Peer median	30.9×

Where Boston Scientific ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Boston Scientific

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.